While Aruna Shanbaug (2011) first recognized the concept of passive euthanasia, it laid down extremely stringent and court-dependent procedures (requiring High Court approval) that made its practical implementation almost impossible. The Common Cause (2018) judgment specifically addressed this procedural deadlock by providing detailed, workable guidelines for 'living wills' or 'advance directives', empowering individuals to make end-of-life choices in advance and outlining a clear, albeit multi-stage, process for their execution.

The 'right to die with dignity' is about an individual's autonomy to refuse medical treatment that merely prolongs suffering when there is no hope of recovery, allowing for a natural and dignified end to life. It is not about actively ending one's life, but about choosing not to artificially prolong it. Conversely, a 'right to commit suicide' implies an active intent to end one's life, irrespective of medical condition, which the Supreme Court has consistently stated is not a part of Article 21.

The Harish Rana case (2026) is highly significant as it marked India's first instance of court-approved passive euthanasia for a person in a Persistent Vegetative State (PVS) *without* a living will. This case clarified that Clinically Assisted Nutrition and Hydration (CANH) is considered 'medical treatment' and can be withdrawn under the guidelines. It reinforced the application of the 'best interest principle' for incapacitated patients who have not made an advance directive, demonstrating the practical implementation of the 2018 judgment and its 2023 modifications.

Despite the 2023 amendments, practical hurdles persist. These include low public awareness about the existence and procedure of living wills, potential reluctance of medical practitioners to withdraw treatment due to ethical dilemmas or fear of legal repercussions, difficulties in promptly constituting and getting consensus from multiple medical boards, and potential emotional disagreements among family members, even with reduced JMFC involvement. The lack of a comprehensive legislative framework also adds to the ambiguity.

A parliamentary law would offer several advantages: it would have greater democratic legitimacy as it involves public debate and legislative process; it could provide a more detailed, robust, and comprehensive framework addressing various nuances of end-of-life care beyond just passive euthanasia; and it would offer greater clarity and certainty for medical professionals, patients, and their families, reducing the ambiguities inherent in judicial guidelines. It would also be more stable and less prone to frequent judicial interpretations.

The Court clarified that Clinically Assisted Nutrition and Hydration (CANH), which involves providing food and water through invasive means like tubes inserted into the stomach, is not merely basic care but an invasive medical procedure requiring skilled intervention. By categorizing CANH as 'medical treatment', the judgment allows for its withdrawal under the passive euthanasia guidelines when it is determined that it only prolongs suffering without any hope of recovery, aligning with the patient's 'right to die with dignity'.

Opponents often raise ethical concerns about the sanctity of life, the potential for misuse (e.g., pressure on vulnerable individuals like the elderly or disabled), and the 'slippery slope' argument that passive euthanasia could eventually lead to active euthanasia. The Common Cause judgment attempts to address these by incorporating stringent safeguards: requiring multiple medical board approvals, involving the JMFC (for attestation), mandating a terminal illness or PVS with no hope of recovery, and emphasizing the 'best interest principle' for incapacitated patients.

Without the Common Cause judgment, a terminally ill patient (or their family, if the patient is incapacitated) would lack a clear and accessible legal framework to refuse life-sustaining treatment. They would either be compelled to continue treatment, prolonging suffering, or face the extremely difficult and practically unworkable process established by the Aruna Shanbaug case, which required High Court intervention. This would effectively deny individuals the autonomy to choose a dignified end to life and could lead to prolonged legal battles and emotional distress.

The 'best interest principle' is applied when an incapacitated patient has not made an advance directive or living will. In such cases, the medical boards and the patient's family/guardian must determine what treatment withdrawal would be in the patient's 'best interest'. This involves considering whether the treatment is futile, only prolongs suffering, and what the patient would have wanted if they were capable of making decisions. It balances medical considerations with the patient's presumed wishes and quality of life.

India's approach, as established by the Common Cause judgment, is conservative and cautious. It strictly limits end-of-life choices to passive euthanasia, focusing on the right to die with dignity by refusing futile medical treatment, and implements robust safeguards. This contrasts sharply with countries like the Netherlands, Belgium, Canada, or some US states, which have legalized active euthanasia or medically assisted suicide under specific, often broader, conditions. India maintains a clear distinction, prohibiting any direct act intended to end life.

While Aruna Shanbaug (2011) first recognized the concept of passive euthanasia, it laid down extremely stringent and court-dependent procedures (requiring High Court approval) that made its practical implementation almost impossible. The Common Cause (2018) judgment specifically addressed this procedural deadlock by providing detailed, workable guidelines for 'living wills' or 'advance directives', empowering individuals to make end-of-life choices in advance and outlining a clear, albeit multi-stage, process for their execution.

The 'right to die with dignity' is about an individual's autonomy to refuse medical treatment that merely prolongs suffering when there is no hope of recovery, allowing for a natural and dignified end to life. It is not about actively ending one's life, but about choosing not to artificially prolong it. Conversely, a 'right to commit suicide' implies an active intent to end one's life, irrespective of medical condition, which the Supreme Court has consistently stated is not a part of Article 21.

The Harish Rana case (2026) is highly significant as it marked India's first instance of court-approved passive euthanasia for a person in a Persistent Vegetative State (PVS) *without* a living will. This case clarified that Clinically Assisted Nutrition and Hydration (CANH) is considered 'medical treatment' and can be withdrawn under the guidelines. It reinforced the application of the 'best interest principle' for incapacitated patients who have not made an advance directive, demonstrating the practical implementation of the 2018 judgment and its 2023 modifications.

Despite the 2023 amendments, practical hurdles persist. These include low public awareness about the existence and procedure of living wills, potential reluctance of medical practitioners to withdraw treatment due to ethical dilemmas or fear of legal repercussions, difficulties in promptly constituting and getting consensus from multiple medical boards, and potential emotional disagreements among family members, even with reduced JMFC involvement. The lack of a comprehensive legislative framework also adds to the ambiguity.

A parliamentary law would offer several advantages: it would have greater democratic legitimacy as it involves public debate and legislative process; it could provide a more detailed, robust, and comprehensive framework addressing various nuances of end-of-life care beyond just passive euthanasia; and it would offer greater clarity and certainty for medical professionals, patients, and their families, reducing the ambiguities inherent in judicial guidelines. It would also be more stable and less prone to frequent judicial interpretations.

The Court clarified that Clinically Assisted Nutrition and Hydration (CANH), which involves providing food and water through invasive means like tubes inserted into the stomach, is not merely basic care but an invasive medical procedure requiring skilled intervention. By categorizing CANH as 'medical treatment', the judgment allows for its withdrawal under the passive euthanasia guidelines when it is determined that it only prolongs suffering without any hope of recovery, aligning with the patient's 'right to die with dignity'.

Opponents often raise ethical concerns about the sanctity of life, the potential for misuse (e.g., pressure on vulnerable individuals like the elderly or disabled), and the 'slippery slope' argument that passive euthanasia could eventually lead to active euthanasia. The Common Cause judgment attempts to address these by incorporating stringent safeguards: requiring multiple medical board approvals, involving the JMFC (for attestation), mandating a terminal illness or PVS with no hope of recovery, and emphasizing the 'best interest principle' for incapacitated patients.

Without the Common Cause judgment, a terminally ill patient (or their family, if the patient is incapacitated) would lack a clear and accessible legal framework to refuse life-sustaining treatment. They would either be compelled to continue treatment, prolonging suffering, or face the extremely difficult and practically unworkable process established by the Aruna Shanbaug case, which required High Court intervention. This would effectively deny individuals the autonomy to choose a dignified end to life and could lead to prolonged legal battles and emotional distress.

The 'best interest principle' is applied when an incapacitated patient has not made an advance directive or living will. In such cases, the medical boards and the patient's family/guardian must determine what treatment withdrawal would be in the patient's 'best interest'. This involves considering whether the treatment is futile, only prolongs suffering, and what the patient would have wanted if they were capable of making decisions. It balances medical considerations with the patient's presumed wishes and quality of life.

India's approach, as established by the Common Cause judgment, is conservative and cautious. It strictly limits end-of-life choices to passive euthanasia, focusing on the right to die with dignity by refusing futile medical treatment, and implements robust safeguards. This contrasts sharply with countries like the Netherlands, Belgium, Canada, or some US states, which have legalized active euthanasia or medically assisted suicide under specific, often broader, conditions. India maintains a clear distinction, prohibiting any direct act intended to end life.